PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
27909991-6	2017	The orexin (hypocretin) neuropeptide system is an attractive target, given the recent FDA and PMDA approval of suvorexant for the treatment of insomnia.	suvorexant	111-121	hypocretin neuropeptide precursor	Homo sapiens	4-10